Pharmalink Inc.

Largo, FL

UEI
YKLYY6AFHJF4
CAGE
3FHG9
Primary NAICS
541614 Process, Physical Distribution, and Logistics Consulting Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
8285 Bryan Dairy Rd, Largo, FL 33773, USA
Founded
2000
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $227,179
FY2025 $259,751
FY2024 $351,759
FY2023 $332,595

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $195,999
2 Department of Health and Human Services $31,180

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Pharmalink Inc., a self-certified small disadvantaged business based in Largo, Florida, delivers pharmaceutical reverse distribution and controlled substance destruction services to the Department of Veterans Affairs and Indian Health Service as a prime contractor (100% of recent awards), competing predominantly in full-and-open procurements without set-aside designations, though two indefinite-delivery vehicles carry total small business set-asides.

Pharmalink specializes in the collection, handling, return, and disposal of unused, expired, and near-expired pharmaceuticals, including controlled substance destruction and pharmaceutical waste management, for federal healthcare systems. The company operates as a limited liability company and competes across NAICS 493110 (General Warehousing and Storage) and 492110 (Waste Collection), with work framed under PSC R706 (Support-Management: Logistics Support) and pharmacy-services classifications. Recent representative work includes a $421,683.84 purchase order from Veterans Integrated Service Network 7 (awarded June 1, 2023, performing through May 31, 2028) for reverse distribution services across VA facilities in Birmingham, Alabama; a $305,000 purchase order from VISN 22 (awarded October 1, 2024, performing through December 31, 2027) for pharmaceutical return and disposal in Long Beach, California; and a $64,800 purchase order from Indian Health Service (awarded April 8, 2025, performing through March 31, 2030) for reverse distribution services at the Crownpoint Healthcare Facility in New Mexico.

Pharmalink's customer base concentrates within the VA system and Indian Health Service, with 88% of recent awards spread across five customer entities. Veterans Integrated Service Network 7 anchors the potential-value ranking with $905 thousand across four awards, followed by VISN 15 ($615 thousand across four awards), VISN 22 ($505 thousand across three awards), Indian Health Service ($328 thousand across four awards), and VISN 21 ($239 thousand across six awards). The top parent vehicles include a single-award indefinite delivery contract with VISN 15 (36C25524D0053) with a ceiling of $252,800 and completion date July 31, 2029, carrying three delivery orders worth $362 thousand combined, and a single-award blanket purchase agreement with IHS Phoenix Area Office (75H71223A00013) with a ceiling of $231,250 and completion date September 10, 2028, carrying two BPA calls worth $32 thousand combined. Six awards with combined potential value of $1.1 million reach ultimate completion within the next twenty-four months, presenting recompete exposure for the vendor.

Activity has remained modest and flat, averaging five awards per year over the past five years (2021: 2 awards | 2023: 6 awards | 2024: 6 awards | 2025: 5 awards | 2026: 5 awards), with combined potential value across all 24 recent prime awards of $2.6 million. Of that, $1.2 million has been obligated as of the source date. The SCI dataset, which covers federal service contracts above $150,000, captures only one Pharmalink prime record in FY2024, reflecting $131 thousand in invoiced revenue across 0.1 FTEs at a government-paid rate of approximately $624.81 per hour — a limited view of the vendor's activity, as most Pharmalink awards fall below the SCI reporting threshold and include goods and disposal services not captured in SCI. Pharmalink operates 100% as a prime contractor with no subcontract footprint in the award portfolio or SCI records, building its own delivery teams internally rather than subcontracting significant portions of work.

SBA capabilities narrative

PharmaLink, Inc. is the single source provider for pharmaceutical return and disposal logistic solutions. We provide innovative solutions for pharmacies, hospitals, manufacturers, wholesalers, and more.

Quick answers

Is Pharmalink Inc. registered in SAM.gov?

Yes. Pharmalink Inc.'s SAM.gov registration is active through April 6, 2027.

How much has Pharmalink Inc. received in federal contracts?

Federal contracts obligated $259,751 to Pharmalink Inc. in fiscal year 2025 and $1,171,284 in fiscal years 2023 through 2027.

How does Pharmalink Inc. rank among federal contractors?

Pharmalink Inc. ranked #24 in NAICS 456, #59 in NAICS 562119 and #70 in PSC Q517 in FY2025.

What is Pharmalink Inc.'s most recent federal award?

Pharmalink Inc.'s most recent federal contract award is Reverse distribution of pharmaceuticals for white river service unit (75H71226F28026), from Indian Health Service, on September 11, 2026.

On GovTribe

See Pharmalink Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors